![Chidozie Ugwumba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chidozie Ugwumba
Directeur/Membre du Conseil chez
CTx Operations, Inc.
Fortune : 678 637 $ au 31/05/2026
Profil
Chidozie Kermichael Ugwumba is the founder of Hunting Hill Global Capital LLC.
Current jobs include Director at Clene Nanomedicine, Inc., Director at CTx Operations, Inc. since 2020, Director at Micronoma, Inc., and Managing Partner at Symbiosis Capital Management LLC since 2021.
Former jobs include Managing Director at WIT LLC from 2018 to 2021, Director at Stellular Bio, Inc. from 2021 to 2022, Independent Director at Carisma Therapeutics, Inc. from 2020 to 2024, Independent Director at Clene, Inc. from 2020 to 2023, Analyst at Neuberger Berman BD LLC (Investment Management) from 2006 to 2010, Board Member at Maat Pharma SA from 2020 to 2021, and Assistant Vice President at Partners Group Inc (United States) from 2015 to 2018.
Education includes an undergraduate degree from Amherst College conferred in 2003, an MBA from Cornell University conferred in 2015, and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLENE INC 0,81 % | 12/05/2026 | 103 417 ( 0,81 % ) | 678 416 $ | 31/05/2026 |
| 31/05/2025 | 2 215 877 ( 5,3 % ) | 222 $ | 31/05/2026 |
Postes actifs de Chidozie Ugwumba
| Sociétés | Poste | Début |
|---|---|---|
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Directeur/Membre du Conseil | 01/12/2020 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Directeur/Membre du Conseil | - |
Symbiosis Capital Management LLC
 Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 01/01/2021 |
Micronoma, Inc.
 Micronoma, Inc. Medical/Nursing ServicesHealth Services Operates as cancer diagnostic company | Directeur/Membre du Conseil | - |
Anciens postes connus de Chidozie Ugwumba
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2024 |
| CLENE INC. | Directeur/Membre du Conseil | 15/02/2023 |
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Directeur/Membre du Conseil | 31/12/2022 |
WIT LLC
 WIT LLC Investment ManagersFinance Profile Unavailable. | Director of Investments | 01/01/2021 |
| MAAT PHARMA | Directeur/Membre du Conseil | 01/01/2021 |
Formation de Chidozie Ugwumba
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Neuberger Berman BD LLC
 Neuberger Berman BD LLC Investment ManagersFinance NBBD-IM offers clients investment solutions across asset classes, styles, capitalizations and geographies in both public and private markets, as well as multi-asset class solutions that bring them all together. For equity investments, the firm tends to focus on stocks with solid balance sheets, relatively low price-to-earnings ratios, low price-to-cash flow ratios, strong cash flows, above-average yields, sustainable earnings growth, reasonable valuation multiples relative to growth prospects, sound franchise values and significant insider ownership. They use both top-down and bottom-up analysis to select investments. In addition, the firm uses options and futures and occasionally invests in ADRs and private equity opportunities. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hunting Hill Global Capital LLC
 Hunting Hill Global Capital LLC Investment ManagersFinance Hunting Hill aims to provide attractive risk-adjusted absolute returns over the course of a full business cycle. Their Funds’ investment strategy seeks to capitalize on trading opportunities in a range of situations where idiosyncratic events—macroeconomic shocks, monetary/fiscal policy decisions, regulatory activity, corporate actions, or other sources of volatility— have disrupted intrinsic relationships between security prices. | Finance |
WIT LLC
WIT LLC Investment ManagersFinance Profile Unavailable. | Finance |
Maat Pharma SA
 Maat Pharma SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops and commercializes patient-microbiome symbiosis to improve survival outcomes in oncology | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology to produce independent human platelets from human induced pluripotent stem cells | Commercial Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
Partners Group Inc (United States)
 Partners Group Inc (United States) Investment ManagersFinance Partners Group invests in companies located across the globe. the firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. It also acts as a co-investor. | Finance |
Micronoma, Inc.
Micronoma, Inc. Medical/Nursing ServicesHealth Services Operates as cancer diagnostic company | Health Services |
Clene, Inc.
 Clene, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Symbiosis Capital Management LLC
Symbiosis Capital Management LLC Investment ManagersFinance SymBiosis invests in both public and private companies located in the united States. The firm targets companies operating in the fields of the biotechnology. It provides financing for seed, early and later stage capital requirements. | Finance |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
Choisissez Zonebourse 
